1. Home
  2. Labeler Index
  3. Lannett Company, Inc.
  4. 0527-2580
  5. Product Images: Fluvastatin Sodium

Product Images Fluvastatin Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Fluvastatin Sodium NDC 0527-2580 by Lannett Company, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1. Primary Endpoint – Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population) - figure 1

Figure 1. Primary Endpoint – Recurrent Cardiac Events (Cardiac Death, Nonfatal MI or Revascularization Procedure) (ITT Population) - figure 1

Figure 2. Fluvastatin Capsules Intervention Prevention Study - Primary and Secondary Endpoints - figure 2

Figure 2. Fluvastatin Capsules Intervention Prevention Study - Primary and Secondary Endpoints - figure 2

The text describes the results of a study comparing the effectiveness of Fluvastatin with a Placebo in reducing cardiac events, such as cardiac deaths, non-fatal MI, and revascularization. The study showed a risk reduction in primary endpoints, and secondary endpoints such as revascularization, with a higher incidence observed in placebo group patients. The study excluded revascularization of the target lesion within the first 6 months of the initial procedure.*

Figure 3 Change in Minimum Lumen Diameter (mm) - figure 3

Figure 3 Change in Minimum Lumen Diameter (mm) - figure 3

Figure 4 Change in % Diameter Stenosis - figure 4

Figure 4 Change in % Diameter Stenosis - figure 4

Commercial label design - fluvastatin label sciecure

Commercial label design - fluvastatin label sciecure

Each tablet contains 80 mg of fluvastatin sodium, a USP equivalent. The usual dosage information can be found in the package insert, and the tablets should be stored at a controlled room temperature, with excursions permitted to a range between 15-30°C. The medication should be protected from light and dispensed in a tight container. This medication is an extended-release tablet, distributed by Lannett Company, forRx-only use, and its active ingredient is from Beiing Sciecure Pharmaceutical Co. Ltd. The product's NDC number is 0527-2580-32 with 30 tablets in a package. It is important to keep this and all drugs away from children.*

fluvastatin label

fluvastatin label

This is a description of Fluvastatin Sodium extended-release tablets, with a strength of 1080 mg. The recommended storage temperature is 25°C with excursions to 15.30°C. It is advised to keep the tablets in a tight container away from light, and out of reach of children. The manufacturer is Beijing Sciecure Pharmaceutical Co. Ltd and the product is distributed by Lannett Company, Inc. with an NDC of 0527-2580-37. The usual dosage is mentioned in the package insert. This product is only available with a prescription.*

Fluvastatin sodium structural formula - fluvastatin sodium structure2

Fluvastatin sodium structural formula - fluvastatin sodium structure2

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.